Literature DB >> 11445451

Y2K+1 state-of-the-art on non-peptide phosphoantigens, a novel category of immunostimulatory molecules.

E Espinosa1, C Belmant, H Sicard, R Poupot, M Bonneville, J J Fournié.   

Abstract

Some human T cells are activated in vivo and in vitro by small non-peptide antigens, so-called phosphoantigens. Since their discovery in 1994, several reports have continuously documented novel members of this category of immunostimulatory molecules. This article reviews the current knowledge on their biochemical properties.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11445451     DOI： 10.1016/s1286-4579(01)01420-4

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  7 in total

1.  Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells.

Authors:  Matthias Eberl; Hassan Jomaa; Adrian C Hayday
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

2.  Accumulation of a potent gammadelta T-cell stimulator after deletion of the lytB gene in Escherichia coli.

Authors:  Matthias Eberl; Boran Altincicek; Ann-Kristin Kollas; Silke Sanderbrand; Ute Bahr; Armin Reichenberg; Ewald Beck; Donald Foster; Jochen Wiesner; Martin Hintz; Hassan Jomaa
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

3.  BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.

Authors:  Mahboob Salim; Timothy J Knowles; Alfie T Baker; Martin S Davey; Mark Jeeves; Pooja Sridhar; John Wilkie; Carrie R Willcox; Hachemi Kadri; Taher E Taher; Pierre Vantourout; Adrian Hayday; Youcef Mehellou; Fiyaz Mohammed; Benjamin E Willcox
Journal:  ACS Chem Biol       Date:  2017-09-14       Impact factor: 5.100

Review 4.  Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells.

Authors:  Christelle Harly; Cassie-Marie Peigné; Emmanuel Scotet
Journal:  Front Immunol       Date:  2015-01-05       Impact factor: 7.561

Review 5.  The ABP Dendrimer, a Drug-Candidate against Inflammatory Diseases That Triggers the Activation of Interleukin-10 Producing Immune Cells.

Authors:  Séverine Fruchon; Rémy Poupot
Journal:  Molecules       Date:  2018-05-25       Impact factor: 4.411

Review 6.  Our evolving understanding of the role of the γδ T cell receptor in γδ T cell mediated immunity.

Authors:  Benjamin S Gully; Jamie Rossjohn; Martin S Davey
Journal:  Biochem Soc Trans       Date:  2021-11-01       Impact factor: 5.407

7.  Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.

Authors:  Sylvain Nguyen; Mathieu F Chevalier; Sulayman Benmerzoug; Valérie Cesson; Anna K Schneider; Sonia-Cristina Rodrigues-Dias; Florence Dartiguenave; Ilaria Lucca; Patrice Jichlinski; Beat Roth; Denise Nardelli-Haefliger; Laurent Derré
Journal:  J Immunother Cancer       Date:  2022-08       Impact factor: 12.469
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.